I hope your investment pays off. I've lost big time here in the past all while encouraging others to be patient because I believed management could change for the better. But I had to finally see the reality before me.
RGBP hired a firm at 10K/month to promote and seek partnerships. That company was an expert according to it's website for $1-5 million dollar deals, not $1-5B deals. To date other than the "we have been in conversations with big pharma" released in PRs for over 4 years now without any concrete funding, licensing or partnerships, we have no news of anything. There are still 2 people besides the hired firm employed to raise funds, but with all the progress and time passed, no news other than insider shares and funding at .01-.05/share when the stock then traded between .15-.20/share.
Now the recent PRs state that they "have decided" to not strike any partnerships until they have developed the science further and the recent scientific progress also has extended the timeframe previously given for establishing a strengthened candidate for small molecule testing.
We can only guess at what the real reasons are for these decisions, but the facts of the matter are that they don't have any influx of money other than selling more shares, they have a FDA approved pipeline product gathering dust on the shelves; they had other pipeline products being developed under contracts with prestigious doctors and institutions about which we have heard absolutely nothing for months; the 2 main scientists on which most of the pipeline products were based are no longer with the company... and the volume of interest in the stock has all but dried up, with a good day seeing less than $5,000 dollars in stock traded.
To go from where we are today to a projected Billion dollar deal is quite the dream. Lander's has basically told us that while they might release updates, the next step in the current development of NR2F6 product development is more than 5 months away without any other product development, interest or activity that we know of other than Koos continuing to spin companies, restructure internal shares and the like.
Given all of the above and the lessons I've learned losing a great portion of my investments here, I expect the stock price to drift further down before any hope of a sustained upward climb. When it drops to .02 or below, I may buy back some of the shares I've had to sell at great loss.
Great science, less than great management.
